Virtus Investment Advisers’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95.4K Buy
9,183
+1,023
+13% +$10.6K 0.03% 351
2025
Q1
$108K Buy
+8,160
New +$108K 0.03% 411